Clinical Outcomes of Drug‐Eluting Stents and Drug‐Coated Balloons in Tortuous Small Coronary Lesions
Catheterization and Cardiovascular Interventions · 19.08.2026
DOI: 10.1002/ccd.70814 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 19.08.2026. Verfasst von Shunichiro Ishio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Gunma, Japan. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Angioplasty, Balloon, Coronary, Coronary Artery Disease, Coated Materials, Biocompatible. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
In small, tortuous coronary lesions, the long‐term comparative performance of drug‐coated balloon (DCB) angioplasty versus drug‐eluting stent (DES) treatment remains uncertain, despite both strategies being widely used in contemporary percutaneous coronary intervention (PCI) practice.
Aims
This study aimed to compare 3‐year clinical outcomes between DES and DCB in patients undergoing PCI for small, tortuous coronary lesions.
Methods
This retrospective, single‐center study included 366 patients treated with either DES ( n = 226) or DCB ( n = 140) for lesions with at least one angulation ≥ 45°. The primary endpoint was major adverse cardiac events (MACE). Time‐to‐event outcomes were assessed using Kaplan–Meier analysis and Cox proportional hazards models.
Results
Procedural success rates were high and comparable between groups. At 3 years, MACE occurred more frequently in the DCB group than in the DES group (log‐rank p = 0.013). In multivariable analysis, DCB use remained associated with higher risks of MACE (hazard ratio [HR] 1.88; 95% confidence interval [CI] 1.12–3.16; p = 0.017) and target vessel revascularization (TVR) (HR 1.84; 95% CI 1.01–3.21; p = 0.045). Subgroup analysis showed that DES had significantly better outcomes than DCB in lesions with mild‐to‐moderate tortuosity, whereas event rates were similar between groups in severely tortuous segments.
Conclusion
In small, tortuous coronary lesions, DES use was associated with lower rates of MACE and TVR at 3 years than DCB use. The advantage of DES was most apparent in mild‐to‐moderate tortuosity, whereas it was not statistically significant in severely tortuous vessels. These findings highlight the importance of anatomic complexity when selecting a treatment strategy for tortuous coronary lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Gunma, Japan.
ORCID-Profile: Shunichiro Ishio, Takashi Nagasaka, Ryota Taniuchi, Shiro Amanai, Yohei Ishibashi, Noriaki Takama, Hideki Ishii
Zitieren
APA
Ishio, S., Nagasaka, T., Taniuchi, R., Amanai, S., Ishibashi, Y., Takama, N., & Ishii, H. (2026). Clinical Outcomes of Drug‐Eluting Stents and Drug‐Coated Balloons in Tortuous Small Coronary Lesions. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70814
Vancouver
Ishio S, Nagasaka T, Taniuchi R, Amanai S, Ishibashi Y, Takama N, et al. Clinical Outcomes of Drug‐Eluting Stents and Drug‐Coated Balloons in Tortuous Small Coronary Lesions. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70814
BibTeX
@article{Ishio2026,
author = {Ishio, Shunichiro and Nagasaka, Takashi and Taniuchi, Ryota and Amanai, Shiro and Ishibashi, Yohei and Takama, Noriaki and Ishii, Hideki},
title = {Clinical Outcomes of Drug‐Eluting Stents and Drug‐Coated Balloons in Tortuous Small Coronary Lesions},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70814}
}
EUVIMED